Susanna High
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Start not stated–2024-10-01
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Dyne Therapeutics, Inc. (DYN) | Chief Operating Officer | $497,888 | $2,045,442 |
| 2022 | Dyne Therapeutics, Inc. (DYN) | Chief Operating Officer | $467,500 | $1,594,292 |
| 2021 | Dyne Therapeutics, Inc. (DYN) | Chief Operating Officer | $425,000 | $1,690,621 |
| 2020 | Dyne Therapeutics, Inc. (DYN) | Chief Operating Officer | $167,788 | $3,745,915 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.